Cargando…

Refractory Myasthenia Gravis Treated Successfully with Rituximab: A Case Report

Detalles Bibliográficos
Autores principales:	Rahul, L Yadav, Dakua, Tulsiprasad, Mukherjee, Arabinda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682758/ https://www.ncbi.nlm.nih.gov/pubmed/29184357 http://dx.doi.org/10.4103/aian.AIAN_233_17

Ejemplares similares

Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin
por: Kovács, Edina, et al.
Publicado: (2017)

Refractory myasthenia gravis – clinical profile, comorbidities and response to rituximab
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2016)

Rituximab treatment in myasthenia gravis
por: Vesperinas-Castro, Ana, et al.
Publicado: (2023)

Myasthenia gravis: A challenge
por: Ramesh, Bhagyalakshmi
Publicado: (2015)

Subgroup Classification of Myasthenia Gravis
por: Renjen, Pushpendra N.
Publicado: (2021)

Rituximab in Refractory Myasthenia Gravis: Experience in a Single Healthcare Center in Mexico
por: López-Hernández, Juan Carlos, et al.
Publicado: (2021)

COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
por: Ramaswamy, Swathi Beladakere, et al.
Publicado: (2020)

Refractory generalized myasthenia gravis with myasthenic incomplete ophthalmoplegia successfully treated with eculizumab
por: Weidmayer, Sara L., et al.
Publicado: (2023)

Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: Case report and review of literature
por: Aryani, Omid, et al.
Publicado: (2017)

Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis
por: Verma, Neha, et al.
Publicado: (2021)

Eculizumab versus rituximab in generalised myasthenia gravis
por: Nelke, Christopher, et al.
Publicado: (2022)

Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis
por: Bastakoti, Sanjiv, et al.
Publicado: (2021)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Nephrotic syndrome after thymectomy for myasthenia gravis
por: Kute, V. B., et al.
Publicado: (2013)

The perianaesthetic management of a patient with myasthenia gravis
por: Singh, Anisha, et al.
Publicado: (2023)

Successful administration of electroconvulsive therapy in a patient with treatment-resistant schizophrenia and coexisting myasthenia gravis
por: Sreeraj, Vanteemar S., et al.
Publicado: (2019)

Management of thoracoscopic thymectomy in a myasthenia gravis patient
por: Adate, Kavita, et al.
Publicado: (2011)

Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2020)

Understanding the burden of refractory myasthenia gravis
por: Schneider-Gold, Christiane, et al.
Publicado: (2019)

Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis
por: Harris, Linda, et al.
Publicado: (2019)

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
por: Garnero, Martina, et al.
Publicado: (2018)

Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients
por: Yevgi, Recep, et al.
Publicado: (2021)

New-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Özenç, Betül, et al.
Publicado: (2022)

Rituximab in refractory myasthenia gravis: a prospective, open‐label study with long‐term follow‐up
por: Anderson, Dustin, et al.
Publicado: (2016)

Effectiveness and Safety of Rituximab for Refractory Myasthenia Gravis: A Systematic Review and Single-Arm Meta-Analysis
por: Zhao, Cong, et al.
Publicado: (2021)

Systemic Lupus Erythematosus and Myasthenia Gravis in a Male Patient: an HLA Case Investigated
por: Klimi, Eleni, et al.
Publicado: (2021)

Sweet taste loss in myasthenia gravis: more than a coincidence?
por: Chabwine, Joelle N, et al.
Publicado: (2014)

Myasthenia Gravis Associated with Acute Hepatitis E Infection in Immunocompetent Woman
por: Belbezier, Aude, et al.
Publicado: (2014)

Electronic health record derived-impact of COVID-19 on myasthenia gravis
por: Roy, Bhaskar, et al.
Publicado: (2021)

Clinical Characteristics of Refractory Myasthenia Gravis Patients
por: Suh, Joome, et al.
Publicado: (2013)

Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis
por: Choi, Kyomin, et al.
Publicado: (2019)

Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome?
por: Ren, Jingru, et al.
Publicado: (2023)

Emergency cesarian section in a patient of myasthenia gravis: Is neuraxial anesthesia safe?
por: Mundada, Surbhi D., et al.
Publicado: (2012)

Clinical characteristics and outcomes of patients with overlapping Miller Fisher syndrome and myasthenia gravis
por: Yuan, Jun-Liang, et al.
Publicado: (2019)

Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links
por: Singh, Shalendra, et al.
Publicado: (2022)

Eculizumab improved weakness and taste disorder in thymoma-associated generalized myasthenia gravis with anti-striational antibodies: A case report
por: Amano, Eiichiro, et al.
Publicado: (2019)

Eculizumab improves fatigue in refractory generalized myasthenia gravis
por: Andersen, Henning, et al.
Publicado: (2019)

Frequency and clinical features of treatment-refractory myasthenia gravis
por: Rath, Jakob, et al.
Publicado: (2019)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
por: Schneider-Gold, Christiane, et al.
Publicado: (2017)

Seronegative Myasthenia Gravis in Association with Human T-Lymphotropic Virus Type 1 and Hepatitis C
por: Amin, Saad Muhammad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ngpnml5026kkogh0ilcpc0vd4c